Hubner, Richard A <br/><br/>
Gemcitabine plus capecitabine in unselected patients with advanced pancreatic cancer.  [electronic resource] 

 -  Pancreas  Apr 2013 
 - 511-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1536-4828 
<br/><br/><label>Standard No.: </label>10.1097/MPA.0b013e31826c6aee  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Capecitabine<br/>Deoxycytidine--administration & dosage<br/>Diarrhea--chemically induced<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Hand-Foot Syndrome--etiology<br/>Humans<br/>Lethargy--chemically induced<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Pancreatic Neoplasms--drug therapy<br/>Prognosis<br/>Survival Analysis<br/>Treatment Outcome<br/>Young Adult<br/>Gemcitabine